Physician profile
Yanghee Woo
NPI 1588802870
$130,615.93
in general payments reported to CMS, 2019-2025
11 companies · $36K in 2025
The $36K reported for 2025 was more than what 98% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $4,210 · 2021: $8,974 · 2022: $24K · 2023: $16K · 2024: $24K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,000 · Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $54,605.00 |
| Travel and Lodging | $11,933.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,000.00 |
| Food and Beverage | $1,055.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $108,860.11 | 2019-2025 | Echelon Flex, Harmonic, Enseal |
| Intuitive Surgical, INC. | $12,880.87 | 2021-2024 | |
| Astrazeneca Pharmaceuticals Lp | $5,504.99 | 2024-2025 | Imfinzi |
| Medical Device Business Services, INC. | $3,045.24 | 2020-2025 | |
| Eisai INC. | $75.66 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $65.53 | 2024 | |
| Virtual Incision Corporation | $59.00 | 2024 | Mira |
| Bayer Healthcare Pharmaceuticals INC. | $43.48 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $35.30 | 2024 | Keytruda |
| Tempus Ai, INC | $28.97 | 2024 | |
| Advanced Accelerator Applications | $16.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanghee Woo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.